Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
ARK Invest Dumps Nvidia (NVDA), Meta (META), AMD (AMD), and Tesla (TSLA) — Pivots to Healthcare Stock
Key Highlights
Table of Contents
Toggle
Key Highlights
Semiconductor Sector Faces Widespread Reduction
Healthcare Sector Receives Capital Allocation
On March 27, ARK Invest divested 58,119 Nvidia shares valued at approximately $9.95M, continuing a previous day’s sale of 154,000 shares.
Meta Platforms experienced a 10,500-share reduction worth $5.75M amid ongoing legal challenges related to youth protection on social platforms.
Following a 2.76% decline to $361.83, Tesla position was reduced by 4,221 shares for roughly $1.57M after downward delivery guidance revision.
Semiconductor holdings AMD and Teradyne faced reductions totaling $3.9M and $5.08M respectively.
In a contrarian move, ARK acquired 48,659 Arcturus Therapeutics (ARCT) shares for approximately $344,505, bolstering healthcare exposure.
Cathie Wood’s investment firm ARK Invest maintained its technology divestment strategy on Friday, March 27, marking another chapter in a week-long rebalancing across its exchange-traded fund portfolio.
This latest round of transactions occurred just 24 hours after ARK liquidated more than $84 million in technology holdings, establishing a clear trend: reduced tech exposure coupled with heightened risk management.
ACROSS ARK’s ARKK, ARKW, and ARKF portfolios, the firm offloaded 58,119 Nvidia shares representing roughly $9.95 million in value. This transaction followed the previous session’s divestment of 155,441 Nvidia shares totaling $27.77 million. Market analysts point to elevated artificial intelligence sector valuations and developer pushback against Nvidia’s recent product offerings as contributing factors.
NVIDIA Corporation, NVDA
Meta Platforms faced additional selling pressure as ARK liquidated 10,500 shares generating $5.75 million in proceeds. The previous trading session saw 76,622 Meta shares sold for $45.58 million. Judicial decisions concerning social media platforms’ impact on minors have intensified scrutiny on Meta, potentially exposing the company to regulatory penalties and stricter oversight.
ARK also reduced its Tesla exposure, selling 4,221 shares for approximately $1.57 million. The electric vehicle manufacturer’s stock had declined 2.76% to $361.83 following management’s announcement reducing 2026 delivery projections from 1.75 million to 1.69 million units.
Semiconductor Sector Faces Widespread Reduction
The chip industry witnessed comprehensive position trimming across ARK’s holdings. The firm disposed of 19,126 AMD shares generating $3.90 million, supplementing the prior session’s 38,245-share sale worth $8.42 million. Teradyne experienced a 17,092-share reduction valued at $5.08 million, following Thursday’s divestment of 16,009 shares for $5.18 million.
This broad-based semiconductor selling suggests mounting apprehension regarding supply chain limitations and valuation concerns following the sector’s extended rally.
Streaming platform Roku witnessed a modest reduction of 9,274 shares for $825,664. Additionally, ARK sold 37,876 Bullish (BLSH) shares totaling $1.38 million, maintaining a consistent divestment pattern in this holding.
Healthcare Sector Receives Capital Allocation
Contrasting sharply with technology sector activity, ARK’s ARKG healthcare-focused ETF executed a purchasing transaction, acquiring 48,659 Arcturus Therapeutics shares for approximately $344,505. This represents ARK’s continued accumulation of ARCT, following a 4,525-share purchase on March 24.
The healthcare acquisition represents the singular buy transaction among ARK’s publicly disclosed trades for the trading session.
Throughout the week, ARK’s technology divestment has been systematic and extensive — positions in Nvidia, Meta, AMD, Teradyne, Tesla, Roku, and Bullish all experienced reductions across multiple trading days.
The $344,505 ARCT share purchase on March 27 constituted the exclusive acquisition during an otherwise divestment-dominated session for the investment firm.
✨ Limited Time Offer
Get 3 Free Stock Ebooks
Advertise Here